NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

If you’re building a company in the “3-D” world of Devices, Diagnostics or Digital health products, you have until the end of the day this Friday, Feb. 16, to seek fame and fortune.

The North Carolina Biotechnology Center’s Piedmont Triad Office is welcoming Gregory Burke, M.D., Stephanie Dance-Barnes, Ph.D., and Joseph Graves Jr., Ph.D., to its regional advisory committee at its October meeting. 
A novel drug candidate aimed at preventing and treating hereditary angioedema (HAE) – a recurrent and severe swelling disorder – has shown positive results in a clinical trial, according to its Durham-based developer, BioCryst
Brii Biosciences, a new biopharmaceutical company with North Carolina roots, has been named to the Fierce 15, an annual listing of notable bioscience startup companies published by the industry publication FierceBiotech.
The world needs a new paradigm for how to feed this planet. Participants in the North Carolina Biotechnology Center’s Ag Tech Professional Forum this week discussed how controlled environments, ranging from shipping containers to huge urban warehouses, offer one way to do more with less.
Cambrex Corp., a contract manufacturer of small-molecule therapeutics, is expanding its facilities and workforce in High Point to meet growing demand for its services. 
Morrisville-based airway products company Circassia is breathing a sigh of relief over a decision by the giant AETNA health insurance company that the NIOX, one of Circassia’s key asthma products, is “medically necessary.
Mispro Biotech Services, a Quebec-based preclinical services company offering research animal vivarium space and support services for life science investigators, has completed a major renovation of its multi-user facility in Research Triangle Park.
Boston-based Indigo Agriculture, which has an expanding facility in Research Triangle Park, has launched an online grain sales platform called MarketPlace that is supported by the closing of a $250 million Series E round of financing.
Precision BioSciences, a Durham-based genome editing company, has formed a strategic collaboration potentially worth more than $445 million with global biopharmaceutical company Gilead Sciences, to develop new therapies aimed at curing hepatitis B infections.
Raleigh-based UVision360 has achieved a dual-indication clearance from the U.S. Food and Drug Administration for its all-in-one LUMINELLE DTx Hysteroscopy System to be used clinically for hysteroscopy and cystoscopy in women.
bluebird bio, a gene therapy company with operations in Durham, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for Lenti-D, its potential treatment for a rare and life-threatening neurological disorder in boys.
North Carolina Central University will soon make it easier for area biopharmaceutical companies to fill job vacancies with qualified employees via online courses offered through NCCU’s Biomanufacturing Research Institute and Technology Enterprise (BRITE).
Grifols, a global biotherapeutics company with major operations in North Carolina, has received approval from the U.S. Food and Drug Administration for a new formulation of GamaSTAN, its medicine for treating patients who’ve been exposed to the hepatitis A or measles viruses.
Research Triangle Park-based CertriRx recently started doing business as Verinetics. But the young company hasn’t changed its focus, or the speed with which it is making inroads in anti-counterfeiting technology.
scroll back to top of page